Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
94.91
+4.91 (5.46%)
At close: Apr 14, 2026, 4:00 PM EDT
94.02
-0.89 (-0.94%)
After-hours: Apr 14, 2026, 6:14 PM EDT
Dianthus Therapeutics Analyst Ratings
Total Analysts
13
Consensus Rating
Strong Buy
Price Target
$121.00
Upside
+27.49%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wolfe Research | Wolfe Research | Buy Initiates $98 | Buy | Initiates | $98 | +3.26% | Apr 9, 2026 |
| Wells Fargo | Wells Fargo | Buy Initiates $135 | Buy | Initiates | $135 | +42.24% | Mar 19, 2026 |
| Wedbush | Wedbush | Buy Maintains $80 → $103 | Buy | Maintains | $80 → $103 | +8.52% | Mar 12, 2026 |
| Wedbush | Wedbush | Buy Maintains $55 → $80 | Buy | Maintains | $55 → $80 | -15.71% | Mar 10, 2026 |
| Raymond James | Raymond James | Buy → Strong Buy Upgrades $63 → $123 | Buy → Strong Buy | Upgrades | $63 → $123 | +29.60% | Mar 10, 2026 |
| Baird | Baird | Buy Maintains $67 → $132 | Buy | Maintains | $67 → $132 | +39.08% | Mar 10, 2026 |
| Clear Street | Clear Street | Strong Buy Maintains $100 → $130 | Strong Buy | Maintains | $100 → $130 | +36.97% | Mar 10, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $47 → $130 | Strong Buy | Maintains | $47 → $130 | +36.97% | Mar 9, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $125 → $145 | Buy | Maintains | $125 → $145 | +52.78% | Mar 9, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $63 → $110 | Strong Buy | Maintains | $63 → $110 | +15.90% | Mar 9, 2026 |
| Guggenheim | Guggenheim | Strong Buy Maintains $100 → $200 | Strong Buy | Maintains | $100 → $200 | +110.73% | Mar 4, 2026 |
| Wedbush | Wedbush | Buy Maintains $46 → $55 | Buy | Maintains | $46 → $55 | -42.05% | Feb 11, 2026 |
| Jefferies | Jefferies | Strong Buy Maintains $66 → $81 | Strong Buy | Maintains | $66 → $81 | -14.66% | Feb 2, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $56 → $63 | Strong Buy | Maintains | $56 → $63 | -33.62% | Jan 8, 2026 |
| Wedbush | Wedbush | Buy Reiterates $46 | Buy | Reiterates | $46 | -51.53% | Dec 22, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $40 → $47 | Strong Buy | Maintains | $40 → $47 | -50.48% | Nov 10, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.